A blood test that estimates the quantity of sugar attached to your red blood cells. A1C provides an estimate of your average blood sugar level over the past two to three months (expressed as a ...

The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which – for the first time – includes recommendations for CGM use in type 2 diabetes, the use of GLP-1 drugs for ...

Managing diabetes and confronting diabetes stigma around the holidays can be especially challenging and stressful. Consider some simple adjustments – like making recipe swaps and incorporating time in ...

Why is this study important? This study will evaluate the effects of different doses of MariTide, an experimental once monthly injectable medication, in people with type 2 diabetes. Early results from ...

U.S. Senator Bernie Sanders reprimanded the FDA for failing to address the rising diabetes and obesity crisis with urgency and action. All parties agreed on the need to combat diabetes and obesity as ...

In a recent clinical trial, tirzepatide achieved 47% greater weight loss compared to semaglutide. More participants lost at least 25% of their initial weight on tirzepatide than on semaglutide.

Early study results found that MariTide, a new potential weight loss drug, showed up to 20% weight loss in people with obesity or overweight, and 17% weight loss with a 2.2% reduction in A1C for ...

People with diabetes are two to three times as likely to have depression than people without, and that depression often goes underdiagnosed. Acceptance and Commitment Therapy (ACT) is a behavioral ...

What is the aim of the study? This phase 3 trial is studying the effects of Renal Autologous Cell Therapy (REACT) injections on eGFR, a measure of kidney function, in adults with a diagnosis of both ...

Researchers are exploring the potential benefits of red light therapy, which involves exposing the body to low-level wavelengths of light to enhance cellular energy production. While research is still ...

A new report from the Centers for Disease Control (CDC) has found that more American adults have diabetes at a rate even higher than previously thought – and many don’t even know they have it.

If you have type 1 or type 2 diabetes and are between 18-80 years old, you may be eligible to join a trial studying whether the drug fenofibrate can prevent the worsening of diabetes-related ...